Invest in the Future of Vision.

Empower Sight. Transform the World.

Join Innovega in delivering life-changing technology to millions of visually impaired people worldwide.

At Innovega, our commitment is clear: Restore vision. Restore independence. Restore quality of life.

We’re not just developing groundbreaking technology. We’re building a future where visual impairment no longer means forfeiting dignity, independence, or connection. We are creating the tools that empower individuals to reclaim their independence, connect with loved ones, and experience the world with unprecedented clarity.

For investors seeking a meaningful impact, Innovega represents a powerful opportunity to transform lives on a global scale.

Innovega

Why Invest in Innovega?

Functional Vision

Clinically Proven Technology

  • Innovega’s patented systems have already shown life-changing results through clinical trials and user testing.
  • Proven ability to restore functional vision to legally blind patients and enhance clarity for those with moderate impairment.
  • FDA-regulated technology, ensuring safety, efficacy, and credibility within medical and consumer markets.

Market Enterprises

Market Opportunity & Demand

  • Addressing a $50 billion global market, encompassing 295 million visually impaired individuals.

  • Serving highly underserved patient populations with innovative, accessible solutions.
  • Broad application potential spanning healthcare, defense, sports, consumer technology, and enterprise markets.

Business Model

Scalable Business Model

  • Diverse revenue streams include hardware sales, software subscriptions, insurance reimbursement, strategic licensing, and enterprise partnerships.
  • Vision-as-a-Service model provides recurring revenue, enhancing long-term financial stability.

Innovation & Momentum

Patented Innovation & Strategic Momentum

  • Over 80 filed patents covering critical aspects of technology integration, display systems, and medical-grade solutions.
  • $6M+ in contracts secured with prestigious organizations including the U.S. Army, DARPA, NIH, NSF, Microsoft and Oakley (acquired by EssilorLuxottica).

Visionaries

Team of Visionaries

  • Led by industry experts with extensive expertise in optics, medical devices, AR/VR, and scalable innovation.
  • Supported by a distinguished advisory board including executives from Bausch & Lomb, Intel Capital, and Microsoft, as well as world-renowned low-vision specialists who have consulted for the FDA and are shaping the future of wearable vision technology.

  • Unified by a shared mission of delivering real-world impact to those who need it most.

Status

Clinical Status

  • Completed
    Phase I / Phase II Human Subject Testing
  • In Process
    Phase II Contact Lens Optimization / Ph III Preparation

scalable Technology

Future-Proof Platform

  • Built for commercialization and rapid growth.
  • Strong IP portfolio positioning us as the leader in vision restoration technology.

Vision Revolution

Broad Application Potential

Innovega’s groundbreaking technology extends far beyond personal vision restoration. Our patented systems are designed to revolutionize multiple industries, enhancing experiences and capabilities where clarity, precision, and accessibility are paramount.

innovega

What We’re Building

A world where vision loss doesn’t mean life loss. A future where those struggling with visual impairment have options that are comfortable, stylish, and genuinely effective. This isn’t just innovation…it’s Innovega…and we’re only getting started.

invest today

Ready to be part of the
Vision Revolution?

Ready to be part of the Vision Revolution?

Explore our investment opportunities and join a mission that’s changing lives.